Michael is a Co-Founder and General Partner at Flare Capital Partners.
Previously, Michael was the founding General Partner of Flybridge Capital Partners, and earlier in his career was with Polaris Partners, as well as held positions at Wasserstein Perella & Co. and Morgan Stanley & Co.
Current and prior board seats include Aspen RxHealth, Author Health, Axuall, BlueTarp Financial, Cayaba Care, Circulation, Cohere Health, Explorys, Functional Neuromodulation, HealthVerity, higi, Inbound Health, Iora Health, MicroCHIPS, Nuvesse, Oshi Health, PolyRemedy, Predictive Biosciences, Predilytics, RightMove Health, T2 Biosystems, TARIS Biomedical, VidSys, Welltok (observer), and three recent stealth portfolio companies, two of which were co-created with Flare Capital strategic Limited Partners. Additionally, Michael served on the board of International Data Group, the founding partner of IDG Capital, a leading venture capital fund in China and other important innovation centers in Asia, and is on the board of The Forsyth Institute, the leading Harvard-affiliated oral health research organization.
Michael serves on various innovation and investment advisory boards for Advocate Aurora Health, Boston Children’s Hospital, Cleveland Clinic, and MedStar Health, as well as serving on the Governor’s Digital Health Council and the Massachusetts Technology Collaborative. Michael also serves on the Investment Committee for the Partners Innovation Fund and on is the Advisory Board of Harvard Business School’s Health Care Initiative. He was past chairman of the New England Venture Capital Association and on the board and executive committee of the National Venture Capital Association. Michael earned a BA with honors in chemistry from Williams College and an MBA. from Harvard Business School.
Michael authors a blog focused on venture capital, innovation, and healthcare www.ontheflyingbridge.com.Back To Team